DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
W•••••• T••••••••• I••
Healthcare & Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
Also written as: Emerald JV LP; Inc. - Funded; Inc. 1 Emerald JV LP; Verdelite JV LP
Principal held
at least $45.6M
sum of BDC pieces, a lower bound
Fair value
$45.5M
100c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
11
4 on the latest quarter
Facilities
2
0 equity pieces beside them
Next maturity
Oct 1, 2029
no dated debt inside 24 months
On the tape since
Dec 31, 2021
latest Jun 30, 2026
Events
4
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $30.7M | 100c | S+200 bp | Oct 22, 2029 | 7 |
| other lien unstated | at least $14.9M | 100c | S+200 bp | Oct 22, 2029 | 3 |
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| A••• S•••••••• I••••• F••• | term loan first lien F•••• lien senior secured loan | $28.1M | $28.0M 100c | S+200 bp |
| B••••••••• P•••••• C••••• F••• | unstated lien unstated | $2.1M | $2.1M 100c | S+200 bp |
| B••••••••• P•••••• C••••• F••• | unstated lien unstated | $6.5M | $6.5M 100c | S+200 bp |
| B••••••••• P•••••• C••••• F••• | unstated lien unstated N••••••••• I••••• | $6.3M | $6.3M 100c | S+200 bp |
| N••••• C•••••••• P•••••• C•••••• I••••• F••• | term loan first lien F•••• L••• D••• | $2.2M | $2.2M 100c | S+200 bp |
| S••••• C•••• C•••••• C••• | term loan first lien F•••• L••• - T••• L••• | $350,000 | $349,000 100c | 2.00% |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 4 | $45.6M | $45.5M | 100c | 0 |
| Mar 31, 2026 | 4 | $45.7M | $45.6M | 100c | 0 |
| Dec 31, 2025 | 5 | $50.4M | $50.7M | 101c | 0 |
| Sep 30, 2025 | 5 | $50.5M | $50.5M | 100c | 0 |
| Jun 30, 2025 | 4 | $43.9M | $44.1M | 100c | 0 |
| Mar 31, 2025 | 3 | $39.7M | $39.5M | 99c | 0 |
| Dec 31, 2024 | 5 | $44.9M | $45.1M | 100c | 0 |
| Sep 30, 2024 | 4 | $31.1M | $31.1M | 100c | 0 |
| Jun 30, 2024 | 4 | $33.8M | $33.8M | 100c | 0 |
| Mar 31, 2024 | 7 | $81.9M | $82.1M | 100c | 0 |
| Dec 31, 2023 | 2 | $44.2M | $44.4M | 101c | 0 |
| Sep 30, 2023 | 2 | $33.8M | $33.8M | 101c | 0 |
| Jun 30, 2023 | 2 | $29.7M | $29.7M | 101c | 0 |
| Mar 31, 2023 | 2 | $15.5M | $15.5M | 100c | 0 |
| Dec 31, 2022 | 2 | $33.3M | $32.8M | 99c | 0 |
| Sep 30, 2022 | 1 | $20.0M | $19.2M | 96c | 0 |
| Dec 31, 2021 | 1 | $46.5M | $46.5M | 100c | 0 |
What changed
- Lender left a facilityDec 31, 2025
- New lender joined a facilitySep 30, 2025
- Spread changed (observed)Dec 31, 2024
- Lender left a facilityDec 31, 2024
- Spread changed (observed)Jun 30, 2024
- Maturity extended (observed)Mar 31, 2024
- Lender left a facilityMar 31, 2024
- New lender joined a facilityMar 31, 2024
- New lender joined a facilityMar 31, 2024
- Lender left a facilityMar 31, 2024
- Lender left a facilityMar 31, 2024
- New lender joined a facilityMar 31, 2024
- Lender left a facilityMar 31, 2024
- New lender joined a facilityMar 31, 2024
- New lender joined a facilityMar 31, 2024
- Maturity extended (observed)Mar 31, 2024
- Maturity extended (observed)Mar 31, 2024
- New borrower on a BDC scheduleDec 31, 2021
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- W•••••• T•••••••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 11 BDCsderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it